ALPS Advisors’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,029
Closed -$117K 1086
2022
Q1
$117K Sell
2,029
-254
-11% -$14.6K ﹤0.01% 822
2021
Q4
$271K Buy
+2,283
New +$271K ﹤0.01% 847